Sun Pharma Q1FY23 results: Prabhudas Lilladher foresees the company’s net profit to rise 27 per cent year-on-year (YoY) to Rs 1,786 crores from Rs 1,445 crores in the year-ago quarter.
Subscribe To Our Free Newsletter |
Sun Pharma Q1FY23 results: Prabhudas Lilladher foresees the company’s net profit to rise 27 per cent year-on-year (YoY) to Rs 1,786 crores from Rs 1,445 crores in the year-ago quarter.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!